Home › REMEL EUROPE LIMITED › Proteus OX19 Agglutinating Serum
Proteus OX19 Agglutinating Serum
REMEL EUROPE LIMITED · Model R30165801 · UDI-DI 05056080501604
0
510(k) clearances
0
Adverse events
2
Recalls
2
Facilities
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2004-10-20 | BD Diagnostic Systems | Febrile Antigens and Control Antisera that were released prior to August 2003 contained the 12/2000 revised insert that had incorrect testing instructions. |
| 2004-10-20 | BD Diagnostic Systems | Febrile Antigens and Control Antisera that were released prior to August 2003 contained the 12/2000 revised insert that had incorrect testing instructions. |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.